Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation

       
Total article views   HTML views PDF downloads Totals
10,249 Dovepress* 9,186+ 2,100 11,286
PubMed Central* 1,063 402 1,465
Totals 10,249 2,502 12,751
*Since 29 January 2015
+Since July 2016

View citations on PubMed Central and Google Scholar